Literature DB >> 34170100

Iron Self-Boosting Polymer Nanoenzyme for Low-Temperature Photothermal-Enhanced Ferrotherapy.

Xiao Cui1, Guihong Lu2, Fang Fang2, Yuan Xiong1, Shuang Tian1, Yingpeng Wan1, Yafang Xiao1, Dong Shen1, Hui Wang1, Jinfeng Zhang2, Chun-Sing Lee1.   

Abstract

In this work, an iron self-boosting polymer nanoenzyme was prepared by using pyrrole-3-carboxylic acid as a monomer and iron as an oxidizing agent via a simple and one-step method [hereafter referred to as FePPy nanoparticles (NPs)]. In fact, researchers previously paid negligible attention on the iron element during the polymerization reaction of polypyrrole, thus the intrinsically catalytic functions and enzymatic activities of the high iron content (wt %: 21.11%) are ignored and not fully explored. As expected, results demonstrate that the as-synthesized FePPy NPs can decompose H2O2 to generate hydroxyl radicals (•OH) which exhibit enzyme characteristics, further inducing a nonapoptotic ferroptosis pathway. Moreover, the nanoenzyme shows impressive photothermal properties which can accelerate the Fenton reactions to enhance ferroptosis. The combined photothermal and ferroptosis therapy of FePPy NPs was found to have high efficacy. With the properties of easy synthesis, high efficacy, and good biocompatibility, the FePPy NPs are considered as potential agents for cancer treatments.

Entities:  

Keywords:  ferroptosis; iron-engineered; low-temperature photothermal therapy; nanoenzyme; self-boosting

Year:  2021        PMID: 34170100     DOI: 10.1021/acsami.1c01658

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  9 in total

1.  Preparation of NIR-Responsive Gold Nanocages as Efficient Carrier for Controlling Release of EGCG in Anticancer Application.

Authors:  Weiran Gao; Xiangyi Fan; Yunlong Bi; Zipeng Zhou; Yajiang Yuan
Journal:  Front Chem       Date:  2022-06-02       Impact factor: 5.545

2.  Nanozyme Hydrogels for Self-Augmented Sonodynamic/Photothermal Combination Therapy.

Authors:  Shuntao Wang; Ning Zeng; Qi Zhang; Mingzhu Chen; Qinqin Huang
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

Review 3.  Extracellular vesicles as bioactive nanotherapeutics: An emerging paradigm for regenerative medicine.

Authors:  Min Li; Fang Fang; Meng Sun; Yinfeng Zhang; Min Hu; Jinfeng Zhang
Journal:  Theranostics       Date:  2022-06-21       Impact factor: 11.600

Review 4.  Targeting regulated cell death in tumor nanomedicines.

Authors:  Qinghu Zeng; Xiangyi Ma; Yangmeihui Song; Qiqing Chen; Qiuling Jiao; Liqiang Zhou
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

Review 5.  Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications.

Authors:  Lianxiang Luo; Han Wang; Wen Tian; Xiaoling Li; Zheng Zhu; Riming Huang; Hui Luo
Journal:  Theranostics       Date:  2021-10-22       Impact factor: 11.556

Review 6.  Multifunctional Nanomaterials for Ferroptotic Cancer Therapy.

Authors:  Zhiyuan Shi; Jianzhong Zheng; Wenbin Tang; Yang Bai; Lei Zhang; Zuodong Xuan; Huimin Sun; Chen Shao
Journal:  Front Chem       Date:  2022-03-24       Impact factor: 5.221

7.  Injectable Hydrogel System for Camptothecin Initiated Nanocatalytic Tumor Therapy With High Performance.

Authors:  Shuntao Wang; Qi Zhang; Ning Zeng; Pengyuan Qi; Chunyu Huang; Qinqin Huang
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

8.  Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy.

Authors:  Weiwei Zeng; Mian Yu; Ting Chen; Yuanqi Liu; Yunfei Yi; Chenyi Huang; Jia Tang; Hanyue Li; Meitong Ou; Tianqi Wang; Meiying Wu; Lin Mei
Journal:  Adv Sci (Weinh)       Date:  2022-06-09       Impact factor: 17.521

9.  Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy.

Authors:  Xiangtian Deng; Renliang Zhao; Qingcheng Song; Yiran Zhang; Haiyue Zhao; Hongzhi Hu; Zhen Zhang; Weijian Liu; Wei Lin; Guanglin Wang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.